Pediatric Patients

Tikun Olam treats hundreds of children that unfortunately dealing with various health conditions.

Tikun Olam has always been committed to making medical Cannabis accessible to vulnerable populations that can benefit from the cure and relief medical cannabis can provide. The treatment supports the children fight with Cancer, to mitigate some of the most difficult side effects of chemotherapy, and to relieve symptoms associated with various metabolic and neurological diseases, such as Epilepsy and Autism.

Tikun Olam’s commitment to children has guided the company to producing unique cannabis products created with care for our youngest patients including specialized cannabis oils, cannabis capsules, and cannabis edibles and other products that help make cannabis relief accessible to children fighting diseases and conditions.

The company partners with researchers, doctors, nurses, institutions and organizations to promote and conduct medical research on cannabis for children. Many of Israelis leading hospitals and researchers have chosen Tikun Olam’s unique cannabis varieties for their research and for their treatment options and our activities in these sectors are continuously expanding.

Tikun Olam has unique cannabis varieties, including strains that have naturally high levels of CBD and low levels of THC. These strains help form the basis of many of the products produced especially for children.

Tikun Olam is honored and proud to treat hundreds of pediatric patients with thrilling results promoting a significant positive change for these brave inspiring families. 

The world's first test group of cannabis treatment for pediatric patients from the Autism spectrum disorders, is treated by Tikun Olam. The results are exciting and soon we'll begin a clinical study on this subject.

For information about the research studies we’re associated with that are expanding the treatment options for children, please click here.




1. Effects of Avidekel on Dystonia and Spasticity of Cerebral Palsy Paediatric Patients

Significant Improvement in Spasticity and Dystonia, Sleep Difficulties, Pain Severity and Quality of Life

Clinical random trial examined the effects of Avidekel oil on dystonia and spasticity in children who suffer from CP or genetic impairment.

Results have shown significant improvement in spasticity and dystonia, sleep difficulties, pain severity, and quality of life was observed.  Adverse effect included worsening of seizures in two patients; behavioral changes in two patients; somnolence in one patient.

Head ResearcherDr. Luba Blumkin, Wolfson Hospital

2. Effects of Cannabis on children diagnosed with ASD (Autistic spectrum disorder)

The patients showed 75% improvement in ASD comorbidities symptoms

Retrospective cohort study of 53 patients. study product: Avidekel oil 1:20 and Erez oil 3%

Dr. Orit Stoler, Assaf Harofeh Medical Center

3. Effects of Medical Cannabis on Children and Adolescents with Epilepsy:

Most of the patients (89%) reported some reduction in seizure frequency

Retrospective cohort study of 74 patients.The purpose of the study to describe the experience of five Israeli pediatric epilepsy clinics treating children and adolescents diagnosed as having intractable epilepsy with a regimen of medical cannabis oil including Abidkl  oil 1:20.

Chief Researcher: Dr. Michal Zadok

Medical centers: Sheba, Sourasky, Wolfson, Assaf Harofeh, MCU MOH

To download the full study click here


Cannabis for kids: Israel pioneers pediatric pot by cnbc, Dina Gusovsky